CALCIUM (3S) TETRAHYDRO-3-FURANYL(1S,2R)-3-[[(4-AMINOPHENYL) SULFONYL] (ISOBUTYL) AMINO] -1-BENZYL-2- (PHOSPHONOOXY) PROPYLCARBAMATE

CALCIUM (3S) TETRAHYDRO-3-FURANYL(1S,2R)-3-[[(4-AMINOPHENYL) SULFONYL] (ISOBUTYL) AMINO] -1-BENZYL-2- (PHOSPHONOOXY) PROPYLCARBAMATE

The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SINGH HARDEV, ARMITAGE IAN GORDON, SEARLE ANDREW DAVID
Format: Patent
Sprache:eng ; pol
Schlagworte:
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SINGH HARDEV
ARMITAGE IAN GORDON
SEARLE ANDREW DAVID
description The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester (ritonavir), and to the use thereof in the treatment of diseases caused by retroviruses.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL195736BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL195736BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL195736BB13</originalsourceid><addsrcrecordid>eNqNiksKwjAARLtxIeodskzBLNL6wWVSU1JIk5APGEspReJKtFCP4MGt4gFcDDO8efPkVRBRVL4GMLcpcMwZwsPRKJSj0hsig4DYrjOTTqBp4AaRupJKczY9KbBelGpaLYCVVdS7D_waLUAYUSbPQaAMAai5slOkUqeQAm2UDqIghpKaOLZMZtf-NsbVrxcJKJkrOIrDo4vj0F_iPT47LfBhu893lOL8D-UNW-M8Yg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CALCIUM (3S) TETRAHYDRO-3-FURANYL(1S,2R)-3-[[(4-AMINOPHENYL) SULFONYL] (ISOBUTYL) AMINO] -1-BENZYL-2- (PHOSPHONOOXY) PROPYLCARBAMATE</title><source>esp@cenet</source><creator>SINGH HARDEV ; ARMITAGE IAN GORDON ; SEARLE ANDREW DAVID</creator><creatorcontrib>SINGH HARDEV ; ARMITAGE IAN GORDON ; SEARLE ANDREW DAVID</creatorcontrib><description>The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester (ritonavir), and to the use thereof in the treatment of diseases caused by retroviruses.</description><language>eng ; pol</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20071031&amp;DB=EPODOC&amp;CC=PL&amp;NR=195736B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20071031&amp;DB=EPODOC&amp;CC=PL&amp;NR=195736B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SINGH HARDEV</creatorcontrib><creatorcontrib>ARMITAGE IAN GORDON</creatorcontrib><creatorcontrib>SEARLE ANDREW DAVID</creatorcontrib><title>CALCIUM (3S) TETRAHYDRO-3-FURANYL(1S,2R)-3-[[(4-AMINOPHENYL) SULFONYL] (ISOBUTYL) AMINO] -1-BENZYL-2- (PHOSPHONOOXY) PROPYLCARBAMATE</title><description>The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester (ritonavir), and to the use thereof in the treatment of diseases caused by retroviruses.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNiksKwjAARLtxIeodskzBLNL6wWVSU1JIk5APGEspReJKtFCP4MGt4gFcDDO8efPkVRBRVL4GMLcpcMwZwsPRKJSj0hsig4DYrjOTTqBp4AaRupJKczY9KbBelGpaLYCVVdS7D_waLUAYUSbPQaAMAai5slOkUqeQAm2UDqIghpKaOLZMZtf-NsbVrxcJKJkrOIrDo4vj0F_iPT47LfBhu893lOL8D-UNW-M8Yg</recordid><startdate>20071031</startdate><enddate>20071031</enddate><creator>SINGH HARDEV</creator><creator>ARMITAGE IAN GORDON</creator><creator>SEARLE ANDREW DAVID</creator><scope>EVB</scope></search><sort><creationdate>20071031</creationdate><title>CALCIUM (3S) TETRAHYDRO-3-FURANYL(1S,2R)-3-[[(4-AMINOPHENYL) SULFONYL] (ISOBUTYL) AMINO] -1-BENZYL-2- (PHOSPHONOOXY) PROPYLCARBAMATE</title><author>SINGH HARDEV ; ARMITAGE IAN GORDON ; SEARLE ANDREW DAVID</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL195736BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2007</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SINGH HARDEV</creatorcontrib><creatorcontrib>ARMITAGE IAN GORDON</creatorcontrib><creatorcontrib>SEARLE ANDREW DAVID</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SINGH HARDEV</au><au>ARMITAGE IAN GORDON</au><au>SEARLE ANDREW DAVID</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CALCIUM (3S) TETRAHYDRO-3-FURANYL(1S,2R)-3-[[(4-AMINOPHENYL) SULFONYL] (ISOBUTYL) AMINO] -1-BENZYL-2- (PHOSPHONOOXY) PROPYLCARBAMATE</title><date>2007-10-31</date><risdate>2007</risdate><abstract>The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester (ritonavir), and to the use thereof in the treatment of diseases caused by retroviruses.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; pol
recordid cdi_epo_espacenet_PL195736BB1
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title CALCIUM (3S) TETRAHYDRO-3-FURANYL(1S,2R)-3-[[(4-AMINOPHENYL) SULFONYL] (ISOBUTYL) AMINO] -1-BENZYL-2- (PHOSPHONOOXY) PROPYLCARBAMATE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A57%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SINGH%20HARDEV&rft.date=2007-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL195736BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true